Tadalafil Therapy for Pulmonary Arterial Hypertension (vol 119, pg 2894, 2009)

被引：7
|
作者：
Galie
机构：
来源：
CIRCULATION | 2011年 / 124卷 / 10期
关键词：
D O I：
10.1161/CIR.0b013e318231bed1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E279 / E279
页数：1
相关论文
共 50 条
  • [31] Therapy With Inhaled Treprostinil, Macitentan, and Tadalafil/Riociguat in High-Risk Pulmonary Arterial Hypertension
    El-Kersh, Karim
    AMERICAN JOURNAL OF THERAPEUTICS, 2023, 30 (05) : E499 - E502
  • [32] Tadalafil as monotherapy and in combination regimens for the treatment of pulmonary arterial hypertension
    Udeoji, Dioma U.
    Schwarz, Ernst R.
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2012, 7 (01) : 39 - 49
  • [33] Randomized Trial of Macitentan/Tadalafil Single-Tablet Combination Therapy for Pulmonary Arterial Hypertension
    Gruenig, Ekkehard
    Jansa, Pavel
    Fan, Fenling
    Hauser, Jakob A.
    Pannaux, Matthieu
    Morganti, Adele
    Rofael, Hany
    Chin, Kelly M.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (04) : 473 - 484
  • [34] Initial combination therapy with macitentan and tadalafil in patients with pulmonary arterial hypertension, with and without cardiac comorbidities
    McLaughlin, Vallerie V.
    Sitbon, Olivier
    Chin, Kelly M.
    Galie, Nazzareno
    Hoeper, Marius M.
    Kiely, David G.
    MacDonald, Gwen
    Martin, Nicolas
    Mathai, Stephen C.
    Peacock, Andrew
    Tawakol, Ahmed
    Torbicki, Adam
    Noordegraaf, Anton Vonk
    Rosenkranz, Stephan
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 (11) : 2379 - 2391
  • [35] Pulmonary Hypertension: Diagnosis and Management (vol 84, pg 191, 2009)
    McGoon
    Kane
    MAYO CLINIC PROCEEDINGS, 2009, 84 (04) : 386 - 386
  • [36] Obesity in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry (vol 18, pg 229, 2021)
    Min, J.
    Feng, R.
    Badesch, D.
    Berman-Rosenzweig, E.
    Burger, C.
    Chakinala, M.
    De, Marco T.
    Feldman, J.
    Hemnes, A.
    Horn, E. M.
    Lammi, M. R.
    Mathai, S.
    McConnell, J. W.
    Presberg, K.
    Robinson, J.
    Sager, J.
    Shlobin, O. A.
    Simon, M.
    Thenappan, T.
    Ventetuolo, C.
    Al-Naamani, N.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2022, 19 (07) : 1242 - 1242
  • [37] Combination therapy and new types of agents for pulmonary arterial hypertension (vol 28, pg 169, 2007)
    O'Callaghan, Dermot S.
    Gaine, Sean P.
    CLINICS IN CHEST MEDICINE, 2007, 28 (02) : XI - XI
  • [38] Tadalafil therapy for sarcoidosis-associated pulmonary hypertension
    Ford, H. J.
    Baughman, R. P.
    Aris, R.
    Engel, P.
    Donohue, J. F.
    Pulmonary Circulation, 2016, 6 (04) : 557 - 562
  • [39] Obesity in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry (vol 18, pg 229, 2021)
    Lammi, Matthew R.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2021, 18 (07) : 1266 - 1266
  • [40] Therapy of pulmonary arterial hypertension
    Voswinckel, R.
    Reichenberger, F.
    Gall, H.
    Seeger, W.
    Grimminger, F.
    Ghofrani, H. A.
    INTERNIST, 2009, 50 (09): : 1101 - +
12345